25,000
Participants
Start Date
August 1, 2024
Primary Completion Date
August 31, 2030
Study Completion Date
January 31, 2031
Exact Sciences Multicancer Early Detection (MCED) Test
Exact Sciences MCED test, is a qualitative in vitro diagnostic (IVD) for the detection of alterations in circulating tumor DNA and tumor-associated protein levels, which are commonly associated with cancer. It is performed on plasma derived from peripheral blood specimens.
RECRUITING
Endeavor Health, Evanston
RECRUITING
Baylor Scott & White Health, Dallas
Lead Sponsor
Exact Sciences Corporation
INDUSTRY